SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

 Division of Infectious Diseases

[Return To Index page]
photo Ken S. Ho, MD, MPH

Medical Director, Pitt Men's Study, Multicenter AIDS Cohort Study

Medical Director, Project Silk

Pharmacovigilance Safety Officer

Email: hok2@upmc.edu

Phone: 412-383-1675

Contact
Office: Falk Medical Bldg
3601 Fifth Ave., Suite 3A
Pittsburgh, PA 15213
 
Phone: 412-383-1675
Fax: 412-647-7951
E-mail: hok2@upmc.edu
Administrative Assistant:
Patricia Paulson
Address: Keystone Building
3520 Fifth Ave., 5th Fl
Pittsburgh, PA 15213
Email: ppaulson@pitt.edu
Phone: 412-383-1675
Fax: 412-383-2900
Education and Training
Education
B.A., Plant Biology, Cornell University, Ithaca, New York, 1998
Doctor of Medicine, University of Maryland, Baltimore, Maryland, 2004
Master of Public Health, Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland, 2003
Training
Resident, Internal Medicine, University of Pittsburgh, School of Medicine, 2007
Research Interest
Dr. Ho's primary research focuses on biomedical strategies for HIV prevention, and in particular, HIV pre-exposure prophylaxis (PrEP) and microbicide development. He conducts multiple clinical trials of PrEP and microbicides at the University of Pittsburgh Clinical Trial Unit. He was the investigator of record for the Next-PrEP Study (HPTN-069), a safety and tolerability study of maraviroc based regimens for PrEP. He is the protocol chair for MTN-033: An Open Label Randomized Phase 1 Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults. He is also the investigator of record of several other microbicide studies such as DREAM-01 (evaluation of a tenofovir enema) and MTN-026 (Dapivirine gel). Dr. Ho is the Medical Director of the Pitt Mens Study, the Pittsburgh branch of the Multicenter AIDS Cohort Study. He conducts studies of periodic PrEP use and is the principal investigator of the EpiPrEP Pilot Study, which is looking at Intermittent PrEP for HIV prevention among gay, bisexual and other men who have sex with men (msm).
Clinical Interest
Dr. Ho's clinical interests involve HIV PrEP, HIV clinical care, and general infectious diseases. He established the PrEP prophylaxis clinic at the University of Pittsburgh Medical Center in early 2013. He is also an HIV clinician and rounds on the general infectious diseases service.
Publications
For my complete bibliography, Click Here.
Sponsored Research/Activities
Title: Multicenter AIDS Cohort Study (MACS) Participation in the NHLBI Sleep Research Supplement Program
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: U01 AI035043
Start Year: 2016
End Year: 2018
Title: Delivery of Rectal Enema as Microbicide DREAM (Project 1)
Role: Co-Investigator
Funding Agency: Johns Hopkins University
Grant Number: U19 AI113127
Start Year: 2015
End Year: 2019
Title: Feasibility of short-Term PrEP Uptake for MSM with Episodic High-Risk for HIV
Role: Co-Investigator
Funding Agency: National Institute of Mental Health
Grant Number: R34 MH104083
Start Year: 2015
End Year: 2017
Title: Center/Coordination, Analysis and Management / MACS
Role: Co-Investigator
Funding Agency: Johns Hopkins University/National Institute of Allergy & Infectious Diseases
Grant Number: UM1 AI035043
Start Year: 2015
End Year: 2016
Title: University of Pittsburgh Multicenter AIDS Cohort Study (MACS)
Role: Co-Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: U01 AI035041
Start Year: 2014
End Year: 2019
Title: Aids Clinical Trial Group: Core Funding
Role: Co-Investigator
Funding Agency: Brigham and Women's Hospital, Inc.
Grant Number: UM1 AI068636
Start Year: 2014
End Year: 2017
Title: REPRIEVE A5332 and A5333s Protocol Funds
Role: Co-Investigator
Funding Agency: Massachusetts General Hospital/National Heart, Lung, & Blood Institute
Grant Number: U01 HL123336
Start Year: 2014
End Year: 2016
Title: LOC: Microbicides Trials Network
Role: Co-Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: UM1 AI068633
Start Year: 2014
End Year: 2016
Title: Griffithsin-Based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
Role: Co-Investigator
Funding Agency: University of Louisville
Grant Number: U19 AI113182
Start Year: 2014
End Year: 2015
Title: Pitt-Ohio State - Georgetown Clinical Trials Unit
Role: Co-Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: UM1 AI069494
Start Year: 2013
End Year: 2020